Compounds > pomalidomide
Page last updated: 2024-09-04

pomalidomide and mdv 3100

pomalidomide has been researched along with mdv 3100 in 1 studies

Compound Research Comparison

Studies
(pomalidomide)		Trials
(pomalidomide)		Recent Studies (post-2010)
(pomalidomide)		Studies
(mdv 3100)		Trials
(mdv 3100)		Recent Studies (post-2010) (mdv 3100)
6231215521,5461821,502

Protein Interaction Comparison

ProteinTaxonomypomalidomide (IC50)mdv 3100 (IC50)
Gamma-aminobutyric acid receptor subunit piHomo sapiens (human)3
Gamma-aminobutyric acid receptor subunit deltaHomo sapiens (human)3
Prostate-specific antigenHomo sapiens (human)0.13
Androgen receptorHomo sapiens (human)0.8644
Gamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)3
Androgen receptorRattus norvegicus (Norway rat)0.8238
Gamma-aminobutyric acid receptor subunit beta-1Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)3
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)1.26
Gamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit alpha-5Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit alpha-3Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit alpha-4Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit epsilonHomo sapiens (human)3
Gamma-aminobutyric acid receptor subunit alpha-6Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit gamma-1Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit gamma-3Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit thetaHomo sapiens (human)3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ke, Y; Liang, JJ; Liu, HM; Shan, LH; Wang, N; Wang, YL; Wang, ZJ; Xie, H; Yang, RH; Zheng, ZJ; Zhou, C1

Other Studies

1 other study(ies) available for pomalidomide and mdv 3100

ArticleYear
Designed, synthesized and biological evaluation of proteolysis targeting chimeras (PROTACs) as AR degraders for prostate cancer treatment.
    Bioorganic & medicinal chemistry, 2021, 09-01, Volume: 45

    Topics: Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Male; Models, Molecular; Molecular Structure; Prostatic Neoplasms; Proteolysis; Receptors, Androgen; Structure-Activity Relationship

2021